SciSparc Ltd. (NASDAQ:SPRC) Short Interest Update

SciSparc Ltd. (NASDAQ:SPRC) saw a significant drop in short interest in the month of February. As of February 15th, there was short interest totalling 65,200 shares, a drop of 66.9% from the January 31st total of 197,100 shares. Approximately 0.6% of the shares of the company are sold short. Based on an average daily volume of 8,090,000 shares, the short-interest ratio is presently 0.0 days.

SciSparc Price Performance

Shares of SPRC traded up $0.00 during trading hours on Friday, reaching $0.37. 114,765 shares of the company’s stock traded hands, compared to its average volume of 6,471,790. SciSparc has a twelve month low of $0.20 and a twelve month high of $4.10. The business’s fifty day simple moving average is $0.53 and its two-hundred day simple moving average is $0.36.

About SciSparc

SciSparc Ltd., a clinical-stage pharmaceutical company, develops drugs based on cannabinoid therapies. Its drug development programs include SCI-110 for the treatment of Tourette syndrome and Alzheimer's disease and agitation; SCI-160 for the treatment of pain; SCI-210 for the treatment of autism spectrum disorder and status epilepticus; and CannAmide, an anti-inflammatory and chronic pain solution.